# Low-Dose Versus Conventional-Dose Oral Isotretinoin for Acne Vulgaris

> **NCT07639073** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Pakistan Institute of Medical Sciences** · enrollment: 164 (estimated)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** Isotretinoin

## Key facts

- **NCT ID:** NCT07639073
- **Lead sponsor:** Pakistan Institute of Medical Sciences
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07
- **Primary completion:** 2026-10
- **Final completion:** 2026-10
- **Target enrollment:** 164 (ESTIMATED)
- **Last updated:** 2026-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07639073

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07639073, "Low-Dose Versus Conventional-Dose Oral Isotretinoin for Acne Vulgaris". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07639073. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*